SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...

Doctors in Belgium met with a real head-scratcher when an 83-year-old married man came in with a rare form of secondary ...

Get HELLO!'s review of the best places to eat and drink, plus the best activities new to London this November: from an ...

The FMI report, “Bacterial Amylase Market Size, Trends & Forecast 2025–2035,” projects a total value increase of USD 136 ...

This granted U.S. patent represents an important milestone for JayaBio,” said Pawel Krysiak, President and Chief Executive Officer of Jaya Biosciences. “It underscores our commitment to addressing the ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

Deep within the world's oceans lurk marine bacteria armed with plastic-munching enzymes, their evolution seemingly sculpted ...

Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

Grapevine berries possess remarkable metabolic flexibility that enables them to sustain growth even when photosynthetic ...